Sanzyme (P) ltd

About

Company description

We are ambitious Company focused on our core business of Infertility Management and Speciality Probiotic Formulations.

Our people and the customers are our fulcrum of business Our 4 decades of partnership with Sankyo, Japan (now Daiichi-Sankyo) gave us strong technology foundation and international orientation. We are currently expanding our global footprint (exports) into Europe, LATAM, Africa and Asia.
Our best-in-class, cGMP- compliant formulation manufacturing facilities are well-structured with Quality Control lab and Bio Lab to ensure high standards, catering to domestic and International markets, these facilities manufacture a wide range of injectables using aseptic filling / terminal sterilization.
Our well-established Research and Development wing is approved by DSIR (Ministry of Science and Technology) focuses on clinical research and has sophisticated facilities for Analytical, Biological and Microbiological tests and research.

Our major therapy areas :

·         Infertility

·         Gynecology

·         Sexual Health

We are actively working & seeking partnerships across EU, CIS, Africa & Middle East and LATAM markets.
We have completed 350 filings in 50 Countries for Gonadotropins, Hormones, Probiotics & Nutraceuticals while another 650 are in the process.
We are open to collaborate on B2C / B2B models with global partners.

Quick facts

Sales markets	Western Europe; Eastern Europe; Asia; Australia; North America; Central/South America
Affiliated categories:	Biosimilars \|Contract Manufacturing \|Dietary Supplement Ingredients More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 90H83 Book a meeting See our Exhibitor Profile See full Exhibitor List

26 nov 2019

CPhI & PMEC India 2019

26 - 28 November 2019 India Expo Centre, Greater Noida, Delhi NCR Visit us at stand 1A.H09 Book a meeting See our Exhibitor Profile See full Exhibitor List